Enzyme activity of the PIP4K2A gene product polymorphism that is implicated in schizophrenia

Psychopharmacology

Volumn 230, Issue 2, 2013, Pages 329-331

  Clarke, Jonathan H ^a   Irvine, Robin F ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; LIPID; PHOSPHATIDYLINOSITOL 5 PHOSPHATE 4 KINASE; PHOSPHOTRANSFERASE; PROTEIN VARIANT; UNCLASSIFIED DRUG;

DISEASE ASSOCIATION; ENZYME BINDING; ENZYME SUBSTRATE; EXPRESSION VECTOR; EXTRACTION; FLUORESCENCE POLARIZATION; GENE; GENE PRODUCT; GENETIC ASSOCIATION; HUMAN; LETTER; NONLINEAR REGRESSION ANALYSIS; PIP4K2A GENE; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SITE DIRECTED MUTAGENESIS; THIN LAYER CHROMATOGRAPHY;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTAGENESIS, SITE-DIRECTED; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 84891806586     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3299-y     Document Type: Letter

References (11)

1. Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, Khoury MJ, Tanzi RE, Bertram L (2008) Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nature genetics 40:827-834
2. Bakker SC, Hoogendoorn ML, Hendriks J, Verzijlbergen K, Caron S, Verduijn W, Selten JP, Pearson PL, Kahn RS, Sinke RJ (2007) The PIP5K2A and RGS4 genes are differentially associated with deficit and non-deficit schizophrenia. Genes, brain, and behavior 6:113-119
3. Clarke JH, Letcher AJ, D'Santos CS, Halstead JR, Irvine RF, Divecha N (2001) Inositol lipids are regulated during cell cycle progression in the nuclei of murine erythroleukaemia cells. Biochem J 357:905-910
4. Clarke JH, Richardson JP, Hinchliffe KA, Irvine RF (2007) Type II PtdInsP kinases: location, regulation and function. Biochem Soc Symp 74:149-59
5. Di Paolo G, De Camilli P (2006) Phosphoinositides in cell regulation and membrane dynamics. Nature 443:651-657
6. Fedorenko O, Strutz-Seebohm N, Henrion U, Ureche ON, Lang F, Seebohm G, Lang UE (2008) A schizophrenia-linked mutation in PIP5K2A fails to activate neuronal M channels. Psychopharmacology (Berl) 199:47-54
7. Fedorenko O, Tang C, Sopjani M, Foller M, Gehring EM, Strutz-Seebohm N, Ureche ON, Ivanova S, Semke A, Lang F, Seebohm G, Lang UE (2009) PIP5K2A-dependent regulation of excitatory amino acid transporter EAAT3. Psychopharmacology (Berl) 206:429-435
8. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460:748-752
9. Saggers-Gray L, Wildenauer DB, Schwab SG (2011) Expression of PIP4K2A in lymphocyte cell lines from a sample of schizophrenia patients with previous evidence for association. Schizophrenia research 130:295-296
10. Schwab SG, Wildenauer DB (2009) Update on key previously proposed candidate genes for schizophrenia. Curr Opin Psychiatr 22:147-153
11. Schwab SG, Knapp M, Sklar P, Eckstein GN, Sewekow C, Borrmann-Hassenbach M, Albus M, Becker T, Hallmayer JF, Lerer B, Maier W, Wildenauer DB (2006) Evidence for association of DNA sequence variants in the phosphatidylinositol-4- phosphate 5-kinase II alpha gene (PIP5K2A) with schizophrenia. Mol Psychiatr 11:837-846